UBAP2L

Ubiquitin-associated protein 2-like · Q14157 · UBAP2L on Sugi Atlas →

0 patent compounds predicted against UBAP2L, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UBAP2L by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1/PHASE2COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer PHASE1UNKNOWN
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Diagnostic Potential of UCHL1 in Acute Decompensated Heart Failure nanCOMPLETED
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) nanUNKNOWN
Neuronal and Glial Biomarkers in Stroke nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Autophagy Bladder Cancer nanUNKNOWN
Exercise Therapy to Reduce Heart Failure Symptoms; Sorting Mechanisms of Benefit nanCOMPLETED
Using Mobile Technology to Improve Self-Regulation nanCOMPLETED
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas nanRECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia nanCOMPLETED
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods nanUNKNOWN
Association of Autophagy-related Genes ,LncRNA and SNPs With Colorectal Cancer in Egyptian Population nanCOMPLETED
The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma nanWITHDRAWN

Related proteins — ESM-2 sequence neighbours (a UBAP2L binder may also engage these)

ProteinNameSimilarity
Q80X50 1.000 Q80X50 →
UBAP2 Ubiquitin-associated protein 2 0.995 landscape →
Q91VX2 0.994 Q91VX2 →
Q9P2N5 0.979 Q9P2N5 →
P16951 0.978 P16951 →
P51514 0.977 P51514 →
Q9DCB4 0.977 Q9DCB4 →
Q80TM6 0.977 Q80TM6 →
Q61286 0.977 Q61286 →
A0A087WPF7 0.976 A0A087WPF7 →
A0JNC2 0.976 A0JNC2 →
P15336 0.975 P15336 →
Q9NRA8 0.975 Q9NRA8 →
TCF12 Transcription factor 12 0.975 landscape →
P15881 0.975 P15881 →
Q5SFM8 0.975 Q5SFM8 →
Q9Y2K5 0.975 Q9Y2K5 →
O09000 0.975 O09000 →
TCF4 Transcription factor 4 (TCF-4) (Class B basic 0.974 landscape →
YTHDF3 YTH domain-containing family protein 3 0.974 landscape →
O93602 0.974 O93602 →
Q00969 0.974 Q00969 →
Q8VHG2 0.974 Q8VHG2 →
YTHDF1 YTH domain-containing family protein 1 0.973 landscape →
GATAD2B Transcriptional repressor p66-beta 0.973 landscape →
P30985 0.973 P30985 →
A0A0R4IBL7 0.973 A0A0R4IBL7 →
Q8WXX7 0.973 Q8WXX7 →
NCOA1 Nuclear receptor coactivator 1 0.972 landscape →
Q9UBL0 0.971 Q9UBL0 →